Pepsoc.com - The peptide societies network

3rd Natural Peptides to Drugs [NP2D] Congress Report Now Available on the Meeting Website

Exploiting biodiversity for health: antimicrobial peptides, toxins, hormones and more!

The Natural Peptides to Drugs ("NP2D") meeting is an international meeting that is held at Zermatt, Switzerland, near the magnificent Matterhorn mountain in the Alps. This wonderful venue offers unique lectures and opportunities to share knowledge between academic and industrial research leaders as well as industrial and business decision makers.

The concept of the meeting arose from discussions between academic and industrial specialists looking for a form to focus on peptide-based drugs, where everyone is able to experience progresses at the research, development and marketing levels.

The NP2D meeting aims to highlight novel peptide R&D strategies, covering all possible fields from discovery to the market, including aspects such as drug design, production, delivery, intellectual property and regulations. To ensure the congress world class quality and success, the meeting has:

(a) An eminent scientific steering committee:

• Prof. Paul Alewood (University of Queensland, Australia)
• Prof. Richard DiMarchi (Indiana State University, USA)
• Dr Peter Hoffmann (VP at Genzyme Phamaceuticals, Cambridge, USA)
• Dr John Mayer (Eli Lilly, Indianapolis, USA)
• Dr George Miljanich (CEO of Airmid LLC, Redwood City, USA)
• Dr Dimitrios Noukakis (Ecole Polytechnique Fédérale de Lausanne and NP2D organizer, Switzerland)
• Prof. Robin Offord (Executive Director at Mintaka Medical Research Foundation, Geneva, Switzerland)
• Dr Michael Pennington (President & CEO at Bachem Bioscience Inc, King of Prussia, USA)
• Dr Reto Stöcklin (President & CEO at Atheris Laboratories and NP2D organizer, Geneva, Switzerland)
• Dr Timothy Wells (formerly Senior Executive VP of Research at Serono, Geneva, Switzerland)

(b) An advisory board:

• Dr Daniel Bourgin (Director of sales and business development at Lonza AG, Basel, Switzerland)
• Prof. Thomas Ganz (University of California at Los Angeles, USA).

Please visit the conference website to download the full PDF report from the 3rd NP2D Meeting.